These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28633434)

  • 1. PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.
    Singh DK; Gholamalamdari O; Jadaliha M; Ling Li X; Lin YC; Zhang Y; Guang S; Hashemikhabir S; Tiwari S; Zhu YJ; Khan A; Thomas A; Chakraborty A; Macias V; Balla AK; Bhargava R; Janga SC; Ma J; Prasanth SG; Lal A; Prasanth KV
    Carcinogenesis; 2017 Oct; 38(10):966-975. PubMed ID: 28633434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice.
    Wang H; Shun MC; Dickson AK; Engelman AN
    PLoS One; 2015; 10(9):e0137797. PubMed ID: 26367869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations.
    Sutherland HG; Newton K; Brownstein DG; Holmes MC; Kress C; Semple CA; Bickmore WA
    Mol Cell Biol; 2006 Oct; 26(19):7201-10. PubMed ID: 16980622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.
    Pradeepa MM; Sutherland HG; Ule J; Grimes GR; Bickmore WA
    PLoS Genet; 2012; 8(5):e1002717. PubMed ID: 22615581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression.
    Madlala P; Gijsbers R; Christ F; Hombrouck A; Werner L; Mlisana K; An P; Abdool Karim SS; Winkler CA; Debyser Z; Ndung'u T
    AIDS; 2011 Sep; 25(14):1711-9. PubMed ID: 21681054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEDGF/p75 TATA-less promoter is driven by the transcription factor Sp1.
    Desfarges S; Abderrahmani A; Hernàndez-Novoa B; Munoz M; Ciuffi A
    J Mol Biol; 2011 Nov; 414(2):177-93. PubMed ID: 22019592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
    Marshall HM; Ronen K; Berry C; Llano M; Sutherland H; Saenz D; Bickmore W; Poeschla E; Bushman FD
    PLoS One; 2007 Dec; 2(12):e1340. PubMed ID: 18092005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psip1/Ledgf p75 restrains Hox gene expression by recruiting both trithorax and polycomb group proteins.
    Pradeepa MM; Grimes GR; Taylor GC; Sutherland HG; Bickmore WA
    Nucleic Acids Res; 2014 Aug; 42(14):9021-32. PubMed ID: 25056311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-mediated regulation of
    Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
    RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [RNA interference of PC4 and SFRS1 interacting protein 1 inhibits invasion and migration of U87 glioma cells].
    Xiang W; Qi ST; Liu YW; Li HZ; Zhou Q; Yi GZ; Chen ZY; Yan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):802-6. PubMed ID: 27320882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K36me3 and PSIP1/LEDGF associate with several DNA repair proteins, suggesting their role in efficient DNA repair at actively transcribing loci.
    Sundarraj J; Taylor GCA; von Kriegsheim A; Pradeepa MM
    Wellcome Open Res; 2017; 2():83. PubMed ID: 34541330
    [No Abstract]   [Full Text] [Related]  

  • 17. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MANCR lncRNA Modulates Cell-Cycle Progression and Metastasis by Cis-Regulation of Nuclear
    Singh DK; Cong Z; Song YJ; Liu M; Chaudhary R; Liu D; Wang Y; Prasanth R; K C R; Lizarazo S; Akhnoukh M; Gholamalamdari O; Moitra A; Jenkins LM; Bhargava R; Nelson ER; Van Bortle K; Prasanth SG; Prasanth KV
    Mol Cell Biol; 2024; 44(9):372-390. PubMed ID: 39133105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
    Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
    Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.